- Home
- GDTC vs UONEK Comparison
GDTC vs UONEK Comparison
Compare GDTC & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- UONEK
- Stock Information
- Founded
- GDTC 2018
- UONEK 1980
- Country
- GDTC Singapore
- UONEK United States
- Employees
- GDTC N/A
- UONEK N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- UONEK Broadcasting
- Sector
- GDTC Health Care
- UONEK Consumer Discretionary
- Exchange
- GDTC Nasdaq
- UONEK Nasdaq
- Market Cap
- GDTC 21.5M
- UONEK 28.1M
- IPO Year
- GDTC 2023
- UONEK N/A
- Fundamental
- Price
- GDTC $1.89
- UONEK $0.63
- Analyst Decision
- GDTC Buy
- UONEK
- Analyst Count
- GDTC 1
- UONEK 0
- Target Price
- GDTC $5.00
- UONEK N/A
- AVG Volume (30 Days)
- GDTC 18.1K
- UONEK 297.2K
- Earning Date
- GDTC 01-01-0001
- UONEK 08-19-2025
- Dividend Yield
- GDTC N/A
- UONEK N/A
- EPS Growth
- GDTC N/A
- UONEK N/A
- EPS
- GDTC N/A
- UONEK N/A
- Revenue
- GDTC $368,838.00
- UONEK $437,499,000.00
- Revenue This Year
- GDTC $5.37
- UONEK N/A
- Revenue Next Year
- GDTC N/A
- UONEK N/A
- P/E Ratio
- GDTC N/A
- UONEK N/A
- Revenue Growth
- GDTC N/A
- UONEK N/A
- 52 Week Low
- GDTC $1.20
- UONEK $0.44
- 52 Week High
- GDTC $4.05
- UONEK $1.51
- Technical
- Relative Strength Index (RSI)
- GDTC 37.08
- UONEK 47.72
- Support Level
- GDTC $1.85
- UONEK $0.57
- Resistance Level
- GDTC $1.95
- UONEK $0.70
- Average True Range (ATR)
- GDTC 0.10
- UONEK 0.10
- MACD
- GDTC -0.02
- UONEK -0.00
- Stochastic Oscillator
- GDTC 28.00
- UONEK 20.70
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.